title: Biological treatment is approved for severe eosinophilic asthma.
authors.affiliation: London.
authors.forename: Susan
authors.initials: S
authors.lastname: Mayor
mesh_terms: D018927:Anti-Asthmatic Agents / Q000191:economics / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000191:economics / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D006077:Government Agencies; D006801:Humans; D011657:Pulmonary Eosinophilia / Q000188:drug therapy*; D012720:Severity of Illness Index; D006113:United Kingdom
chemical_list: D018927:Anti-Asthmatic Agents; D061067:Antibodies, Monoclonal, Humanized; C434107:mepolizumab